Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia · Delayed Price · Currency is AUD 0.2900
+0.0050 (1.72%)
Feb 19, 2026, 4:10 PM AEST
ASX:PAR Market Cap
ASX:PAR has a market cap or net worth of 127.38 million as of February 18, 2026. Its market cap has decreased by -39.98% in one year.
Market Cap
127.38M
Enterprise Value
110.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.29
Market Cap Chart
Since August 19, 2015, ASX:PAR's market cap has increased from 32.40M to 127.38M, an increase of 293.10%. That is a compound annual growth rate of 13.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 129.58M | -11.06% |
| Dec 31, 2025 | 145.70M | -0.23% |
| Dec 31, 2024 | 146.04M | -2.24% |
| Dec 29, 2023 | 149.39M | -62.33% |
| Dec 30, 2022 | 396.54M | -8.38% |
| Dec 31, 2021 | 432.81M | -25.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Starpharma Holdings | 199.46M |
| Tetratherix | 197.99M |
| Recce Pharmaceuticals | 169.17M |
| Actinogen Medical | 147.13M |
| Botanix Pharmaceuticals | 130.03M |
| Island Pharmaceuticals | 109.06M |
| Arovella Therapeutics | 104.85M |
| Cynata Therapeutics | 90.66M |